Fundraising FoxAgemica
1 known investors
Find your way into Agemica
Sign up to see every warm intro you have to Agemica
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Agemica team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Agemica uses AI to rank disease mechanisms across omics data, targets, and safe-drug libraries, then tests predicted drug combinations in ex-vivo human cancer models to measure cancer-cell death, tumor-volume reduction, and healthy-cell safety. The company advances the strongest candidates toward humanized-mouse studies, IND-enabling work, and clinical development in the AI drug discovery and oncology space.
Founders & leadership
Investors · 1
Frequently asked questions
- What does Agemica do?
- Agemica uses AI to rank disease mechanisms across omics data, targets, and safe-drug libraries, then tests predicted drug combinations in ex-vivo human cancer models to measure cancer-cell death, tumor-volume reduction, and healthy-cell safety. The company advances the strongest candidates toward humanized-mouse studies, IND-enabling work, and clinical development in the AI drug discovery and oncology space.
- Who founded Agemica?
- Agemica was founded by Yasaman KalantarMotamedi.
- Who are Agemica's investors?
- Agemica's investors include Valkyrie.